Sponsor Dossier
Stada Pharmaceuticals
Sponsor Dossier for Stada Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: DUOFILM
- Brand: LECIGON
- Brand: MOVAPO
- Brand: PAROVEN
- Device (sponsor): Patch, nail
- Device (sponsor): Electric infusion pump administration set
- Device (sponsor): General-purpose infusion pump, battery-powered
- Device (sponsor): Wart cryogenic kit
- Device (sponsor): IV line/syringe Luer connector
- Device (sponsor): Tube, feeding, gastrostomy
- Device (sponsor): Tube, feeding, jejunostomy
- Device (sponsor): Wart cryogenic kit
- Device (sponsor): Luer-formatted protective cap
- Device (sponsor): Vial adaptor, non-hermetic
- Device (sponsor): General-purpose infusion pump, battery-powered
- Device (sponsor): Syringe autofill kit
- Device (sponsor): Bag, medical device, reusable
- Device (sponsor): Bag, medical device, reusable
- Device (sponsor): Syringe, hypodermic, metered-delivery
- Device (sponsor): Infusion pump, syringe
About
Stada Pharmaceuticals is an Australian Private Company with ABN 73154966944, registered in NSW and currently active.
Portfolio
Stada Pharmaceuticals has 4 brands on the ARTG, of which 3 are indexable and 2 carry a Product Information document. 2 brands are PBS-listed, 2 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include DUOFILM, LECIGON, MOVAPO, PAROVEN.
Therapeutic focus
— Neurology: 2 brands — Cardiology: 1 brand — Dermatology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2025-07-01, across 2 brands with a PBAC outcome on record.